Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Silverback Therapeutics, Inc. ARS Pharmaceuticals Closes Merger with Silverback Therapeutics November 08, 2022 From Silverback Therapeutics, Inc. Via GlobeNewswire Tickers SBTX Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis October 21, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics and ARS Pharmaceuticals Announce Merger July 21, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference May 17, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update May 12, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results March 31, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference February 24, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference February 03, 2022 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Presents Preclinical Data for SBT8230 at AASLD The Liver Meeting 2021 November 12, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Presents SBT6050-201 Trial in Progress Poster at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting November 12, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the Stifel 2021 Virtual Healthcare Conference November 11, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update November 10, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the H.C. Wainwright Hepatitis B Virus (HBV) Conference October 05, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase 1/1b Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors September 16, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Present Data from its Phase 1/1b Clinical Trial of SBT6050 at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress September 13, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference September 07, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update August 12, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference August 03, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Announces Clinical Supply Agreement with Regeneron to Evaluate SBT6050 in Combination with Libtayo® (cemiplimab), initially in HER2-expressing Non-Small Cell Lung and Gastric Cancers July 07, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the Raymond James Human Health Innovation Conference June 15, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Participate in the Goldman Sachs 42nd Annual Global Healthcare Conference June 01, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics Reports First Quarter 2021 Financial Results May 13, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Silverback Therapeutics to Present SBT6290 Preclinical Data at the AACR 2021 Annual Conference April 08, 2021 From Silverback Therapeutics, Inc. Via Business Wire Tickers SBTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.